Global Diabetic Retinopathy Market 2014-2018

Global Diabetic Retinopathy Market 2014-2018

Category : Healthcare
Published On : June  2014
Pages : 83

------------ Or -------------

About DR and its Treatment Types
DR is defined as an eye disorder that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye which acts as a film for the formation of an image. Long-term diabetes affects the retina as a high blood glucose level can deteriorate and damage the tiny blood vessels in the retina. DR is broadly classified into either non-proliferative DR or proliferative retinopathy. Treatment for DR is dependent on the stage of the disease and is directed at trying to slow or stop the progression of the disease. At present, three types of treatment exist for DR: laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy.
TechNavio's analysts forecast the Global DR market will grow at a CAGR of 6.8 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global DR market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various ophthalmic injections and drugs used in the treatment of DR.
TechNavio's report, the Global DR Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global DR market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
• EMEA        
Key Vendors
• Bayer AG
• F. Hoffmann-La Roche Ltd.
• Novartis AG 
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Valeant Pharmaceuticals International Inc. 
Other Prominent Vendors
• Abbott Laboratories Ltd.
• Alcon Laboratories Inc.
• Alimera Sciences Inc.
• Allergan Inc.
• Ampio Pharmaceuticals Inc.
• Antisense Therapeutics Ltd.
• Bausch & Lomb Inc.
• BCN Peptides SA
• Boehringer Ingelheim GmbH
• Ferrosan Holding A/S
• iCo Therapeutics Inc.
• Isis Pharmaceuticals Inc.
• LPath Inc.
• Lupin Ltd.
• Novast Laboratories Ltd.
• OPKO Health Inc.
• Parexel International Corp.
• pSivida Corp.
• Quark Pharmaceuticals Inc.
• Sirnaomics Inc.
• Thrombogenics NV
• Torrent Pharmaceuticals Ltd.
• Vitreoretinal Technologies Inc.
Key Market Driver
• Increase in Prevalence of Diabetes.
• For a full, detailed list, view our report.
Key Market Challenge
• Lack of Accurate Diagnosis of the Disease.
• For a full, detailed list, view our report.
Key Market Trend
• Increase in Awareness of DR Treatment. 
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

Product Profiles

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Pipeline Snapshot

08. Rate of Incidence and Prevalence

08.1.1 America

08.1.2 Europe

08.1.3 APAC Region

09. Geographical Segmentation

09.1 DR Market in the Americas

09.1.1 Market Size and Forecast

09.2 DR Market in the EMEA Region

09.2.1 Market Size and Forecast

09.3 DR Market in the APAC Region

09.3.1 Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Market Share Analysis 2013

17.3 Other Prominent Vendors

17.4 Future Players Extected To Tap the DR Market

18. Key Vendor Analysis

19. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global DR Market 2013-2018 (US$ million)

Exhibit 3: Global DR Market by Geographical Segmentation

Exhibit 4: DR Market in the Americas 2013-2018 (US$ million)

Exhibit 5: DR Market in the EMEA Region 2013-2018 (US$ million)

Exhibit 6: DR Market in the APAC Region 2013-2018 (US$ million)


Enquiry Before Buy